CRDF
Cardiff Oncology Inc
1.20$
-3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 476.4% | 863.2% | 648.6% | 331.5% | 383.7% | 207.0% | 365.8% | 182.8% | 30.2% | 765,204.5% | 1,634.9% | 2,051.0% | 5,453.6% | 3,094.2% | 3,979.4% | 5,758.1% | 2,099.3% | 2,682.5% | 4,554.2% | 6,057.4% | 4,830.2% | 121.8% | 41.9% | 41.8% | 87.1% | 39.1% | 108.4% | 90.7% | 75.9% | 66.0% | 49.8% | 64.4% | 5,842.4% | 63.6% | – | 9,570.2% | – | 91.8% | 539.0% | – | – | |
| -376.4% | -763.2% | -548.6% | -231.5% | -283.7% | -107.0% | -265.8% | -82.8% | 69.8% | -765,104.5% | -1,534.9% | -1,951.0% | -5,353.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 24.1% | 34.0% | 50.2% | 35.6% | -5,742.4% | 100.0% | 100.0% | -9,470.2% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 4,418.4% | 5,566.2% | 4,503.3% | 962.4% | 1,147.1% | 652.4% | 1,881.3% | 1,746.5% | 2,071.5% | 3,201.3% | 1,635.2% | 2,050.7% | 5,453.6% | 3,094.2% | 3,979.4% | 5,758.1% | 2,099.3% | 2,682.6% | 4,554.2% | 6,057.4% | 4,830.2% | 4,378.9% | 9,740.5% | 8,184.6% | 6,461.3% | 5,032.8% | 10,906.0% | 7,425.9% | 5,689.4% | 4,976.3% | 3,906.3% | 5,823.9% | 5,842.4% | 6,431.8% | 9,611.9% | 9,570.2% | 6,830.8% | 2,088.5% | 16,500.0% | 5,687.5% | 5,108.7% | |
| 3,041.9% | 3,370.6% | 2,311.3% | 3,979.1% | 2,967.3% | 855.1% | 2,501.6% | 1,923.6% | 1,884.5% | 2,159.7% | 910.6% | 1,107.2% | 5,573.3% | 2,944.7% | 2,185.3% | 3,881.4% | 1,208.8% | 2,865.3% | 3,104.2% | 3,516.2% | 2,733.7% | 2,883.5% | 5,324.3% | 2,630.8% | 2,579.6% | 3,987.5% | 3,714.5% | 3,437.0% | 1,704.3% | 2,844.9% | 1,526.8% | 1,690.8% | 1,894.5% | 1,994.0% | 3,682.6% | 2,742.1% | 3,247.5% | 1,232.5% | 14,941.5% | 3,657.7% | 3,311.4% | |
| 10,760.4% | 12,460.3% | 8,296.1% | 5,544.4% | 4,454.9% | 1,665.4% | 4,382.9% | 3,670.1% | 3,956.1% | 5,361.5% | 2,545.7% | 3,158.0% | 11,027.0% | 4,733.2% | 6,164.7% | 9,639.5% | 3,308.1% | 5,547.9% | 7,658.3% | 10,230.9% | 8,237.2% | 7,262.4% | 15,064.9% | 11,575.8% | 9,769.9% | 7,437.5% | 14,620.5% | 11,403.7% | 7,697.9% | 6,657.1% | 5,383.4% | 7,731.9% | 1,894.5% | 8,425.8% | 13,294.5% | 2,742.1% | 10,078.3% | 3,321.0% | 31,441.5% | 9,345.2% | 8,420.1% | |
| -11,136.8% | -14,385.3% | -10,654.3% | -5,772.2% | -4,700.9% | -2,045.4% | -4,648.7% | -3,970.6% | -4,363.1% | -5,261.5% | -2,445.7% | -3,058.0% | -8,140.3% | -4,633.2% | -6,064.7% | -9,539.5% | -3,208.1% | -5,447.9% | -7,558.3% | -10,130.9% | -8,137.2% | -7,162.4% | -14,964.9% | -11,475.8% | -9,669.9% | -7,337.5% | -14,520.5% | -11,303.7% | -7,673.8% | -6,623.1% | -5,333.2% | -7,696.3% | -7,637.0% | -8,325.8% | -13,194.5% | -12,212.4% | -9,978.3% | -3,221.0% | -31,341.5% | -9,245.2% | -8,320.1% | |
| 398.4% | 600.0% | 451.8% | 423.4% | 30.1% | 4.9% | 24.2% | 0.8% | 0.0% | 0.3% | 40.0% | 50.6% | 103.9% | 49.7% | 52.7% | 36.4% | 11.7% | 1.3% | 79.2% | 104.4% | 81.4% | 59.4% | 175.7% | 278.0% | 492.5% | 578.1% | 998.8% | – | – | 531.4% | – | – | – | – | – | – | – | – | – | – | – | |
| -11,436.2% | -12,570.6% | -10,521.6% | -7,887.2% | -3,480.1% | -1,389.2% | -4,779.7% | -3,351.1% | -4,266.1% | -5,332.1% | -2,410.5% | -2,989.1% | -8,012.7% | 1.0% | -6,013.2% | -9,590.7% | -3,306.6% | -5,531.9% | -7,193.1% | -9,936.8% | -8,038.4% | -7,099.2% | -14,855.4% | -11,475.8% | -9,216.1% | -6,794.5% | -13,521.7% | -10,324.1% | -6,901.4% | -5,985.3% | -4,883.4% | -7,225.8% | -7,184.8% | -7,806.0% | -12,324.8% | -11,523.1% | -9,381.7% | -2,969.5% | -30,109.8% | -8,876.9% | -7,884.1% | |
| 299.4% | -1,419.2% | 1,676.9% | 2,112.8% | -1,263.8% | -241.4% | 132.0% | -466.1% | 2.6% | -347.1% | -35.2% | -68.1% | -2.1% | -444.0% | -55.8% | 66.2% | 94.2% | -122.0% | -366.7% | -194.1% | -95.3% | 59.4% | -109.5% | -278.0% | -453.8% | -543.0% | -998.8% | -975.0% | -757.4% | 1,891.0% | 28.6% | – | – | – | – | – | – | – | – | – | – | |
| -11,436.2% | -12,570.6% | -10,521.6% | -7,887.2% | -3,480.1% | -1,389.2% | -4,779.7% | -3,351.1% | -4,266.1% | -5,332.1% | -2,410.5% | -2,989.1% | -8,012.7% | -4,582.7% | -6,013.2% | -9,590.7% | -3,306.6% | -5,531.9% | -7,193.1% | -9,936.8% | -8,038.4% | -7,099.2% | -14,855.4% | -11,475.8% | -9,216.1% | -6,794.5% | -13,521.7% | -10,324.1% | -6,901.4% | -5,985.3% | -4,883.4% | -7,225.8% | -7,184.8% | -7,806.0% | -12,324.8% | -11,523.1% | -9,381.7% | -2,969.5% | -30,109.8% | -8,876.9% | -7,884.1% | |
| -10,908.2% | -11,417.6% | -8,496.5% | -5,772.2% | -3,214.5% | -1,615.7% | -4,525.1% | -3,144.5% | -4,019.0% | -5,129.2% | -2,367.3% | -2,969.4% | -7,955.3% | 394.2% | -5,889.7% | -9,272.1% | -3,123.5% | -5,533.5% | -7,393.1% | -9,776.5% | -7,910.5% | -6,653.4% | -14,813.5% | -11,434.1% | -9,129.0% | -6,727.3% | -13,413.3% | -10,233.3% | -6,825.5% | -5,919.2% | -4,833.7% | -7,161.3% | -7,123.6% | -7,742.4% | -12,115.6% | -11,445.5% | -8,970.0% | -2,877.8% | -29,570.7% | -8,709.6% | -7,665.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.